Evidence map›Paper›PMID 28980279›Full record

Observational studyCardiology journal2019

Secondary prevention of coronary heart disease in elderly population of Turkey: A subgroup analysis of ELDERTURK study.

Salih Kilic, Mutlu Çagan Sümerkan, Volkan Emren, Lütfü Bekar, Sinan Cersit, Elif Tunc, Gülay Gök, Emine Altuntas, Uğur Canpolat, Umit Yasar Sinan and 2 more

Open access · goldAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Cardiology journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 11 institutions in 1 country.

Salih KilicDepartment of Cardiology, Ege University Faculty of Medicine, Izmir, Turkey. kilicsalihhh@gmail.com.
Mutlu Çagan SümerkanDepartment of Cardiology, Sisli Hamidiye Etfal Education and Research Hospital, Istanbul, Turkey.
Volkan EmrenDepartment of Cardiology, Afyonkarahisar State Hospital, Afyon, Turkey.
Lütfü BekarDepartment of Cardiology, Hitit University Corum Education and Research Hospital, Corum, Turkey.
Sinan CersitDepartment of Cardiology, Kosuyolu Kartal Heart Training and Research Hospital, Istanbul, Turkey.
Elif TuncDepartment of Cardiology, Izmir Military Hospital, İzmir, Turkey.
Gülay GökDepartment of Cardiology, Mardin State Hospital, Mardin, Turkey.
Emine AltuntasDepartment of Cardiology, Bingol State Hospital, Bingol, Turkey.
Uğur CanpolatDepartment of Cardiology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Umit Yasar SinanDepartment of Cardiology, Cardiology Institute of İstanbul University, Istanbul, Turkey.
Namık ÖzmenDepartment of Cardiology, GATA Haydarpaşa Training Hospital, Istanbul, Turkey.
Mehdi ZoghiDepartment of Cardiology, Ege University Faculty of Medicine, Izmir, Turkey.
Ege University · TRAfyon Kocatepe University · TRBingöl University · TRGATA Haydarpaşa Eğitim Hastanesi · TRHacettepe University · TRHitit Üniversitesi · TRIstanbul University · TRIzmir University · TRKartal Koşuyolu High Specialization Training and Research Hospital · TRMardin Artuklu University · TRŞişli Etfal Eğitim ve Araştırma Hastanesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSecondary prevention plays an important role after acute coronary event due to high risk of adverse events in elderly. In present study we aimed to evaluate the lifestyle, management of risk factors and medical treatment for secondary protection in elderly patients with known coronary heart disease (CHD).

methodsELDERTURK is a non-interventional, multi-centered, observational study, which included total of 5694 elderly patients ( > 65 years) from 50 centers in Turkey. In this study elderly patients from the ELDERTURK population with known CHD were evaluated for cardiovascular risk factors, comor- bidities and medication usage.

resultsA total of 2976 (52.3% of study) out of 5694 patients included in the ELDERTURK study were evaluated. All had known CHD with a mean age of 73.4 ± 6.2 years and 60.3% were male. 13.0% of patients were smokers, 42.4% were overweight and 21.1% were obese. Only 23.6% of patients reported to do regular exercise, 73.4% had history of hypertension, 47.4% had dyslipidemia and 33.9% had diabetes mellitus. The rate of patients with systolic blood pressure > 140 mmHg were 31.1% and only 13.9% of patients had a recommended ≤ 70 mg/dL level of low-density lipoprotein cholesterol. Anti- platelet, statin, beta-blocker and angiotensin-converting enzyme inhibitor/angiotensin receptor blocker usage was limited to 27.3%.

conclusionsThe ELDERTURK study shows that many patients with CHD have a high prevalence of modifiable risk factors and unhealthy lifestyle. Apart from this, many patients are not receiving thera- peutic intervention and as a consequence most were not achieving the recommended goals.

Indexed as

Life StyleAgedAged, 80 and overAngiotensin-Converting Enzyme InhibitorsCoronary DiseaseFemaleFollow-Up StudiesHumansHydroxymethylglutaryl-CoA Reductase InhibitorsIncidenceMalePlatelet Aggregation InhibitorsPrevalencePrognosisRetrospective StudiesRisk FactorsAngiotensin-Converting Enzyme InhibitorsHydroxymethylglutaryl-CoA Reductase InhibitorsPlatelet Aggregation Inhibitorsagingcoronary diseasedrugsepidemiologypreventiontreatment

Identifiers

PMID28980279
PMCPMC8086687
OpenAlexW2758371401

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.